EcoDrugPlus

Retinoic Acid Receptor Gamma

Ensembl ID : ENSLBEG00000010461
Gene Symbol: RARG
3 Cross references
325 Possible Orthologues:

Retinoic Acid Receptor Gamma-Like

Ensembl ID : ENSLBEG00000017506
Gene Symbol: LOC109992476
3 Cross references
373 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSLBEG00000019702
Gene Symbol: LOC109989670
3 Cross references
225 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSLBEG00000014935
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSLBEG00000002984
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSLBEG00000026455
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSLBEG00000024800
Gene Symbol: RPL14
3 Cross references
309 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSLBEG00000027399
Gene Symbol: RPL15
3 Cross references
357 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSLBEG00000019276
Gene Symbol: RPL17
3 Cross references
710 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSLBEG00000025339
Gene Symbol: RPL18
3 Cross references
379 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSLBEG00000000135
Gene Symbol: RPL18A
3 Cross references
365 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSLBEG00000006095
Gene Symbol: RPL19
4 Cross references
287 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).